Professional Documents
Culture Documents
PERIOPERATIVE CARE
69
Informed consent
Patient information
70
70
Risk
Measuring risk
70
Communicating risk: disclosure of
risk
80
81
Risk management
Mechanical bowel
preparation
81
INFORMED CONSENT
Colorectal surgical practice encompasses invasive surgical interventions that range from outpatient endoscopic
and digital examination to proposing pelvic clearance and
sacrectomy for a recurrent rectal cancer. The purpose of a
colorectal procedure is to restore an individual to health:
a state of complete physical, mental and social well-being,
not merely the absence of disease or infirmity. By the very
nature of the conditions dealt with and the surgical procedures employed, a proportion of patients admitted to a
colorectal service will become ill, develop life-long disability and, in some cases, die from the surgical intervention.
Many patients therefore correctly fear that consenting to
a colorectal procedure could result in mutilation, disruption of body image, destruction of sexuality and an inability to function in society. Perioperative care in colorectal
practice has to address all of these mental, physical and
social concerns when preparing the individual patient and
his or her family for the planned procedure.
The key element in proceeding with an invasive colorectal intervention is to obtain from the patient informed
consent. This is now widely recognised as more than getting a patient to sign a written consent form. The American
Medical Association has defined it as a process of communication between a patient and physician that results in the
patients authorisation or agreement to undergo a specific
medical intervention. The British Medical Association
(BMA) has issued the following principles that not only represent good practice but go beyond the legal minimum for
UK practice:
70
Chapter 3
Perioperative Care
PATIENT INFORMATION
Procedure-specific information that is relevant, understood
and retained by the patient is a key element in informed
consent. Over a timely period the patient and family should
be allowed to develop an informed view of benefits and hazards of the proposed procedure so that they take ownership of the decision to proceed or not to proceed with the
planned surgery. In practice, the proposed procedure, along
with alternative courses of action and possible complications, requires discussion between the patient and the surgeon. It is useful for the patient to be accompanied by a
friend or family member when these discussions take
place. As well as the surgeon, the specialist colorectal
nurse also provides an important source of information.
Torkington et al (2003) examined the sources of information patients and their families used to make a decision as
to whether or not to undergo an ileoanal pouch procedure.
Preoperatively, 59 of 65 (91%) patients felt that the
colorectal nurse specialist and/or the consultant surgeon
had been the most influential source of information in the
decision to have a pouch procedure.
Videotaped or DVD information enhances significantly
patient knowledge about a procedure when compared to
verbal information alone (Rossi et al, 2004). However,
within colorectal practice, both DVDs and leaflets have
been shown to increase a patients knowledge with respect
to cancer surveillance in ulcerative colitis with mean
percentage improvements in scores of 71% [95% confidence interval (CI) 40.2100] and 49% (95% CI 32.166),
respectively (Eaden et al, 2002). As to the content of
patient information leaflets, a comparison has been made
for patients undergoing gynaecological laparoscopy in
which patients were randomised to receive one of two information leaflets. The old leaflet consisted of information
RISK
Risk: an unwanted event that might or might not occur.
MEASURING RISK
Unwanted outcomes in colorectal surgery include postoperative death, formation of a stoma, prolonged postoperative illness, loss of pelvic autonomic function and recurrence
of disease. Of these events, the risk of postoperative death
and illness has been addressed by the development of preoperative scoring systems. Not only are these risk-assessment tools intended to inform individual patients of the risk
they face from a particular procedure, risk-adjusted outcomes are also intended to allow comparison between institutional outcomes and individual surgeon outcomes. Jones
Risk
TABLE 3.1
Crohns disease
GTN (0.2%) ointment
Haemorrhoids
Lateral anal sphincterotomy
Left hemicolectomy
Polyps
Pruritus ani
Rectal cancer
Right hemicolectomy
Tests for bowel problems
Ulcerative colitis
Stomas
http://www.uoa.org
http://www.the-ia.org.uk
ASA grade
The grading system produced by the American Society of
Anesthetists (ASA) (Table 3.2) uses history and examination to give a subjective evaluation of a patients clinical
state before conducting an anaesthetic procedure. If the
procedure is conducted as an emergency, E is added to the
grade to signify a worse prognosis for each category (Jones
and de Cossart, 1999).
In a prospective study of 3250 elective surgical patients,
Klotz et al (1996) confirmed that high ASA grade was asso-
TABLE 3.2
SYSTEM
ASA grade
I
II
III
IV
V
Description
Normal healthy individual
Mild systemic disease that does not limit activity
Severe systemic disease that limits activity but is not incapacitating
Incapacitating systemic disease which is constantly life threatening
Moribund, not expected to survive 24 hours with or without surgery
71
72
Chapter 3
Perioperative Care
Score
1
2
3
4
BUPA
Minor
Intermediate
Major
Major plus
Complex major
1
2
3
4
5
ASA
I
II
III
IV
V
1
2
3
4
5
Cardiopulmonary risk
The Goldman Cardiac Risk Index was specifically designed
to predict the risk of cardiac complications following noncardiac surgery. Nine factors are scored, giving a total possible score of 053, factors included age, myocardial
infarction in the previous 6 months, S3 gallup or jugular
venous congestion, non-sinus rhythm and more than five
premature ventricular contractions per minute (Jones and
de Cossart, 1999). Prause et al (1997) studied 16 227 surgical patients in whom ASA grade and Goldman Cardiac
Risk Index were determined preoperatively. Both indices correlated significantly with perioperative mortality, the ASA
grade showing a closer correlation. A regression tree analysis divided the combination groups into five subgroups; the
mortality was lowest (0.4%) in ASA grade 2 and Goldman
Cardiac Risk Index group I (score 05 points) and increased
up to 7.3% in ASA grade = 4 and Goldman Cardiac Risk
Index group 3 (score > 13 points). Thus, combining both
scores can increase the perioperative prediction of postoperative mortality (Prause et al, 1997) (Figure 3.1).
Gilbert et al (2000) compared four existing methods
for predicting cardiac risk in 2035 patients: ASA,
Goldman Cardiac Risk Index, modified Detsky Index and
the Canadian Cardiovascular Society Index. Cardiac
complications (myocardial infarction, unstable angina,
acute pulmonary oedema or death) were seen in 6.4% of
the patient population. The area under the ROC curve
was 0.625 (95% CI 0.5750.676) for the ASA grade,
0.642 (95% CI 0.5880.695) for the Goldman Index,
0.601 (95% CI 0.5440.657) for the modified Detsky
index and 0.654 (95% CI 0.6010.708) for the Canadian
Cardiovascular Society Index. These values were not significantly different and Gilbert et al (2000) concluded
that existing indices for prediction of cardiac complications perform better than chance, but that no index is
significantly superior to the others.
The prediction of pulmonary complications after noncardiac surgery is less well explored. McAlister et al (2005)
determined the incidence of postoperative pulmonary complications in 1055 consecutive patients attending the
preadmission clinic of a university hospital (mean age 55
years, 50% men, 15% with history of obstructive airways
disease). Overall, 2.7% suffered a significant pulmonary
complication within 7 days of surgery: 13 patients developed respiratory failure requiring ventilatory support, nine
pneumonia, five atelectasis requiring bronchoscopic intervention, and one pneumothorax requiring intervention.
Multivariate analyses revealed that four preoperative factors were independently associated with increased risk of
pulmonary complications: age [odds ratio (OR) 5.9 for age
65 years, P < 0.001], positive cough test (OR 3.8, P =
0.01), perioperative nasogastric tube (OR 7.7, P < 0.001)
and duration of anaesthesia (OR 3.3 for operations lasting
at least 2.5 hours, P = 0.008).
Risk
ASA 3
YES
NO
ASA 2
CRI II
YES
NO
YES
NO
4.40%
7.29%
CRI I
0.40%
YES
NO
1.36%
3.19%
obesity), preoperative diagnosis, anal sphincter manometry (mean resting pressure and squeeze pressure measured
in mmHg) and previous abdominal operations, Other factors taken into consideration included details of surgical
procedures, postoperative pathologic diagnoses along with
the early (within 30 days of surgery) and late complications. Pelvic sepsis was defined as the presence of parapouch abscesses and excluded anastomotic leak and
pouch-related fistulae, which were recorded as separate
complications. Chronic pouchitis was defined as four or
more episodes of pouchitis per year or the need for chronic
antibiotic, immunosuppressive therapy to control symptoms, in addition to endoscopic evidence of pouch inflammation (Fazio et al, 2003). The median patient follow-up
was 4.1 years (range 019 years). Five-year ileal pouch survival was 95.6% (95% CI, 94.496.7). The following risk
factors were found to be independent predictors of pouch
survival: patient diagnosis, prior anal pathology, abnormal
anal manometry, patient comorbidity, pouch-perineal or
pouch-vaginal fistulae, pelvic sepsis, anastomotic stricture
and separation.
Although an interesting approach to counselling and
selecting patients for ileoanal pouch surgery, the ileal pouch
failure model has two significant problems (Marcello,
2004). The first is that of all the numerous factors considered in the model, only four can be determined before surgery: prior anal pathology (perianal abscess, fistula-in-ano,
anal fissure, haemorrhoids), preoperative diagnosis (Crohns
disease versus ulcerative colitis and indeterminate colitis),
patient comorbidity (cardiac, respiratory, renal, diabetes,
morbid obesity) and a weak anal sphincter by manometry.
The other risk factors that arise from pouch surgery and
associated complications are not known when the patient
is trying to get a view of the likelihood of success or failure,
i.e. before committing to the procedure. The second problem
is how applicable is the model to other colorectal centres
offering pouch surgery (Marcello, 2004).
73
74
Chapter 3
Perioperative Care
Score
ACPGBI colorectal
cancer score
Predicted
mortality (%)
Age (years)
< 65
6574
7584
8495
> 95
0
0.7
1.1
1.3
2.6
0
0.10.4
0.50.8
0.91.2
1.31.6
0.8
0.91.1
1.31.7
1.92.5
2.83.7
Cancer resected
ASA I
ASA II
ASA III
ASA IVV
0
0.8
1.6
2.5
1.72.0
2.12.4
2.52.8
2.93.2
4.15.4
6.07.9
8.611.3
12.316.0
1.7
1.8
2.1
2.4
3.33.6
3.74.0
4.14.4
4.54.8
17.422.1
23.929.8
31.938.7
41.148.5
Cancer staging
Dukes A
Dukes B
Dukes C
Dukes D or any metastases
0
0
0.2
0.6
4.95.2
5.35.6
5.76.0
6.16.4
51.058.4
60.867.7
69.975.8
77.682.4
Operative urgency
Elective
Urgent
Emergency
0
0.8
1.1
6.56.8
83.887.4
Risk
Operative
Operative complexity
Multiple procedures
Blood loss
Peritoneal contamination
Extent of malignant spread
Elective versus emergency
surgery
P-POSSUM
Equation
ln R/1 R = 7.04 + (0.13
physiological score) + (0.16
operative score)
Ln R/1 R = 9.065 + (0.1692
physiological score) + (0.1550
operative score)
75
76
Chapter 3
Perioperative Care
No. of
operations
Predicted
deaths
Observed
deaths
22
68
120
77
287
13
13
9
7
42
Operation
Elective
Emergency
Age
< 50
5059
6069
7079
> 80
Total
Observed mortality
(range)
P-POSSUM
mortality
POSSUM
mortality
804
213
3.2 (2.14.7)
23.4 (18.030.0)
3.8
19.5
4.6
16.7
192
149
228
290
158
1017
0.5 (0.12.9)
2.7 (0.76.7)
5.3 (2.79.0)
8.6 (5.712.5)
22.0 (16.029.4)
7.5 (5.99.3)
2.6
3.6
6.2
9.7
12.3
7.1
3.3
6.1
7.5
11.8
12.4
8.2
Risk
TABLE 3.9
1
60
None or mild
100170
40100
10
1316
Minor
None or
serous fluid
Elective
No cancer or
Dukes A,B
2
Moderate
> 170 or 9099
101120
10.115.0
1012.9 or 16.118
Local pus
Dukes C
3
6170
Severe
< 90
> 120 or < 40
> 15.0
< 10 or > 18
4
7180
8
81
Intermediate
Free pus
or faeces
Urgent
Dukes D
Major
Complex major
Emergency
UK-based studies that were used to develop the three prognostic models (Al-Homoud et al, 2004). For each of the
three models, discrimination (as shown by the area under
the ROC curve), was similar in the ACPGBI CRC (77.5%)
and MBO (80.1%) models but was higher in the CRPOSSUM model (89.8%). All three models fitted the data
well, with no significant discrepancies between the
observed and predicted mortality, as tested by the
HosmerLemeshow c statistic (Table 3.10).
The authors concluded that all three predictive models
can be used in everyday practice for preoperative counselling
50
Observed mortality
40
P-POSSUM
Age-adjusted POSSUM
CR-POSSUM
30
20
10
0
04.9
59.9
1019.9
2029.9
30100
0100
Figure 3.2 Calibration of the three Physiological and Operative Severity Scores for the enUmeration of Mortality and morbidity
(POSSUM) models according to the risk of mortality: Portsmouth (P)-POSSUM, age-adjusted POSSUM and colorectal (CR)POSSUM. Each bar represents the mean observed or predicted in-hospital operative mortality rate; error bars indicate the 95%
confidence interval for observed mortality. From Tekkis et al (2004).
77
Chapter 3
Perioperative Care
Discriminationa
77.5% (1.6%)
80.1% (1.9%)
89.8% (1.1%)
Calibrationb
5.98, P = 0.649
7.606, P = 0.473
5.01, P = 0.756
O : E mortalityc (%)
7.5 : 7.5
14.3 : 13.5
5.7 : 5.7
Comparative audit
Between national health systems
Comparison between national health-care systems can be
explored using risk-adjusted data as defined by P-POSSUM
(Bennett-Guerrero et al, 2003). Using Mount Sinai Hospital
as the US centre and Queen Alexandra Hospital and St
Marys Hospital Portsmouth as the UK centres, two comparative populations of surgical patients were identified.
Among the 1056 patients treated in the US, POSSUM physiology scores ranged from 12 to 42 and the operative severity scores from 6 to 37. For the 1539 patients treated in the
UK, respective POSSUM scores ranged from 12 to 52 and
from 9 to 40. The severity of the operations performed in
each country was similar between groups: the US cohort
had a mean (s.d.) (median, interquartile range) operative
severity score of 16.7 (5.7) (17, 1320) and the UK cohort
16.5 (6.2) (16, 1120) (P = 0756). Overall, the mean (s.d.)
(median, interquartile range) postoperative length of stay
in hospital was slightly lower for patients in the US cohort
[10.3 (12.6) (8, 610) days] compared with that for the
UK cohort [11.8 (11.6) (9, 514) days] (P < 07001)
(Bennett-Guerrero et al, 2003). Within both the US and
the UK cohorts, an increase in risk estimated by P-POSSUM
predicted an increase in observed mortality rate (P <
07001). However, for any given risk level (Figure 3.3), the
mortality rates were significantly higher in the UK cohort
than in the US cohort [odds ratio 4.50 (95% CI 2.817.19);
Z = 6725; P < 07001) (Bennett-Guerrero et al, 2003).
Although these differences cannot be generalised to the
entire US and UK health-care systems, these findings
should stimulate further exploration into potential causes
100
UK cohort
US cohort
90
Model-based risk of death (%)
78
80
70
60
50
40
30
20
10
0
10
20
30
40
50
60
70
80
90 100
Risk
BEFORE
Average rank
1
2
3.3
4.3
5
7
7.3
11
11.3
11.5
12.3
14
Hospital
%
Code
0.0
A
p
0.026
Rank
1
Hospital
O/E
Code
B
0.28
Rank
1
0.0001
0.6
0.48
0.020
0.7
0.49
0.030
1.1
0.50
0.006
1.2
0.51
0.012
1.2
0.52
0.014
1.4
0.62
0.0005
1.5
0.69
0.006
1.5
0.70
0.009
1.6
10
0.72
10
0.033
1.7
11
0.77
11
0.026
1.9
12
Misclassified by
unadjusted
mortality rate
BEFORE
AFTER
High outlier surgical services ranked High outlier surgical services ranked by
by observed 30-day mortality rate (%) risk-adjusted O/E ratios for 30-day mortality
p
0.035
AFTER
Hospital
%
Code
Hospital
O/E Rank
Code
K
1.23 111
4.0
107
0.036
4.1
108
1.33
112
0.017
4.2
109
1.34
113
0.014
4.2
110
1.35
114
0.002
4.3
111
1.37
115
0.015
4.3
112
1.37
116
0.016
4.3
113
1.40
117
0.011
4.4
114
1.46
118
0.003
4.5
115
1.46
119
0.031
4.6
116
1.48
120
4.7
117
1.50
121
0.001
0.006
Rank
4.8
118
1.68
122
0.001
4.9
119
2.31
123
0.0007
4.9
120
0.00007
5.2
121
0.007
5.3
122
0.007
7.1
123
Misclassified by
unadjusted
mortality rate
79
80
Chapter 3
Perioperative Care
Between surgeons
Human nature is, however, less interested in institutional
performance than in the question Who is the surgeon who
is least likely to kill me and most likely to fix me?
This question fits with the moves in recent years to
increase openness and transparency in the delivery of
health care. In the UK, this has been accelerated by the
Bristol Royal Infirmary inquiry into paediatric surgical
deaths (Bridgewater, 2005). This inquiry included 198 recommendations, of which two stated that patients must be
able to obtain information on the relative performance of
the Trust and of consultant units within the Trust. This led
to an increasing belief that the interests of the public and
patients would be served by publication of individuals surgical performance in the form of postoperative mortality
(Keogh et al, 2004).
In the US, outcomes attributable to individual cardiac
surgeons in New York were dragged into the public arena
in December 1991. The New York department of health
was sued by a newspaper, Newsday, using the states
Freedom of Information Law. The lawsuit was lost and
the surgeon-specific mortality data was given to Newsday,
and published in December 1991 (Chassin et al, 1996).
Interestingly no movement of patients away from hospitals
with high mortality rates has occurred. Thus, in 1989,
8.7% of all patients undergoing CABG were treated at hospitals whose risk-adjusted mortality rates were significantly
higher than the State average, and 15.7% were treated at
hospitals with significantly lower rates. The comparable figures in 1993 were 9.5% and 17.0%, respectively (Chassin
et al, 1996).
Recently, the Freedom of Information Act has become
law in England and Wales. This gives individuals the right
to obtain data from public organisations. Under the Act, it
is inevitable that individual surgeon data will come into the
public domain. Some individual hospitals are responding
by putting results on the internet (Bridgewater, 2005). If
it is to be useful to the public and fair to individual surgeons
(Bridgewater, 2005), mortality data:
Comparison of individual surgeon outcomes after colorectal resection using unadjusted data demonstrates wide
variations: morbidity varying from 13.6% to 30.6% and
mortality from 4.5% to 6.9%. However, risk-adjusted
analysis based on POSSUM scores demonstrated that the
predicted outcomes expected for each surgeons casemix
were very similar to those observed (Sagar et al, 1996).
Tekkis et al (2000) similarly found that the mortality rates
among the four surgeons varied from 7.6% to 14.7%. The
observed-to-expected ratio of deaths for the original POSSUM equation was only 0.45 to 0.56 but for P-POSSUM
the predictor equation for mortality was close to unity
(0.905 to 1.067) for all four surgeons.
Keogh et al (2004) point out that although the surgeon
plays an important role in surgical outcome, so do many
other important factors. These include which patients are
selected for surgery, which is affected by socioeconomic status of the local population, prevalence of comorbidities,
threshold of referral from the general practitioner and
threshold of acceptance by the surgeon. In addition, there
is the influence of the entire health-care infrastructure
the anaesthetist, the intensive care physician, the surgical/
high-dependency nurse, the junior surgical staff enmeshed
with local standards of anaesthesia, surgery and intensive
care; adequacy of facilities and staffing levels; attitudes
towards training; interpersonal relationships between staff;
and the geographical layout of the unit (for example, in
some units the wards are so far from the theatre that surgeons have no time to check-up on ward patients between
surgery cases).
In the authors view this complex interaction cannot be
reflected in surgeon-specific outcomes. We agree with the
approach taken in the VA medical centres outlined above,
i.e. the National VA Surgical Quality Improvement
Program (NSQUIP; Khuri et al, 1998). This approach
overtly recognises that the performance of a surgeon cannot be separated from that of his or her institution, as quality is highly dependent on institutional systems. For
health-care systems to develop these comparative audits,
investment is required in valid data collection and processing that generates meaningful institutional outcomes, which can in turn be used for constructive service
improvement.
COMMUNICATING RISK:
DISCLOSURE OF RISK
The right to free and informed consent is an international
obligation placed on all health-care workers (Moumjid and
Callu, 2003). The new medical conversation integrates risk
communication into the doctorpatient consultation
(Edwards, 2003). The information offered should be simple, relevant, and responsive to the needs and values of the
individual patient. Difficult and complex risks will require
a series of consultations, at the end of which both surgeon
and patient might have to share the same uncertainties as
to the outcome of the proposed procedure (Edwards,
2003).
The first barrier, for both professional and patient, is in
understanding the arithmetic size of the proposed risk:
moving from innumeracy to insight (Gigerenzer and
Edwards, 2003). Three classes of numerical representation
that lead to confusionsingle-event probabilities, conditional probabilities and relative risksare discussed by
Gigerenzer and Edwards (2003). In their account they
consider ways in which alternative representations might
promote insight (Table 3.12).
In most colorectal surgical consultations, single-event
probabilities are presented in the course of discussing a surgical intervention. Thus, for a patient being counselled for
elective colorectal cancer resection (5% mortality), it would
be appropriate to inform the patient and his or her family
that, of every 20 patients admitted for resection, one
patient dies within 30 days of the procedure. However,
presenting risk to a patient is not only about the numerical data but also the context in which it is presented.
For effective risk communication, the colorectal surgeon
has to display both competence and a caring approach
Risk Management
Examples
You have a 30% chance of a side effect
from this drug
Conditional probabilities
Relative risks
RISK MANAGEMENT
MECHANICAL BOWEL PREPARATION
The need for some method of bowel preparation was
proposed soon after the introduction of colonic resection
rather than colostomy for the management of large bowel
disease (Reybar, 1844; Wilkie, 1938). In the past, clinicians relied upon a period of starvation (allowing liquids
only for 45 days), purgation (usually with magnesium
salts), enemata and rectal washouts (Rogers, 1971, Miller,
1975). During the 1970s and 1980s new techniques were
introduced, largely to improve patient compliance and
reduce the length of preoperative hospital stay (Huddy
et al, 1990; Lee et al, 1996). In this section we present a
detailed account of mechanical bowel preparation for
patients undergoing colonic resection and/or endoscopic
inspection of the colon. This is because for many colorectal surgeons in the USA and the UK, colonic preparation
continues to be a cornerstone of modern elective colorectal surgery in preventing sepsis (Nichols et al, 2005).
Others, however, take an entirely contrary view in which
mechanical bowel preparation before elective colonic surgery is viewed as injurious to the patient (Fearon et al,
2005).
Distal preparation
Enemata are essential if sigmoidoscopy is uninformative
because of gross faecal residue. This is particularly relevant
to pouch surveillance after restorative proctocolectomy as
well as for examination of the rectum after ileorectal anastomosis. Devlin et al (1979) compared dioctyl sodium sulphosuccinate (1% w/v) with sodium acid phosphate (10%) and
with soap enemata (5% w/v). All three preparations were
equally successful for rigid sigmoidoscopy. Although the
dioctyl and phosphate enemata were more expensive than
the soap enemata, the added cost of the proprietary preparations was justified by reduced nursing time. An outpatient
flexible sigmoidoscopy is often desirable in a patient with a
suspected carcinoma in the sigmoid which cannot be visualised or biopsied with the rigid instrument. In this situation,
a disposable phosphate enema is superior to the small volume
Microlax (Silverman and Keighley, 1985).
81
82
Chapter 3
Perioperative Care
and can be associated with flattening of the surface epithelial cells, goblet-cell depletion and increased oedema in the
lamina propria (Gaginella and Phillips, 1976; Saunders
et al, 1977; Meisel et al, 1977). By contrast, GoLytely was
associated with minimal changes on light microscopy
(Pockros and Foroozan, 1985). Fa-Si-Oen and Penninckx
(2004) compared full-thickness surgical colonic biopsies
from 20 patients who received a normal meal the night
before surgery with biopsies from 20 patients that had
undergone colonic cleansing with polyethylene glycol.
After assessing five microscopic criteria of damage to the
colonic wall the authors concluded that polyethylene glycol caused no significant additional tissue damage. Others
have reported that sodium phosphate can produce aphthous ulcers and that they are more common than in
patients prepared with polyethylene glycol electrolyte solutions (Hixson, 1995; Zwas et al, 1996). Nevertheless, these
lesions have not been observed elsewhere (Curran and
Plosker, 2004) either at endoscopy or from resection specimens (Kolts et al, 1993; Cohen et al, 1994; Oliveira et al,
1997). Furthermore, oral whole-bowel irrigation is often
poorly tolerated and cannot be completed in a high proportion of patients (Burbridge et al, 1978; King et al, 1979;
Thomas et al, 1982; Ernstoff et al, 1983; Adler et al, 1984;
DiPalma et al, 1984; Kohler et al, 1990; Cohen et al, 1994;
Chia et al, 1995; Oliveira et al, 1997).
Colonoscopy preparation with sodium phosphate has
been reported as superior to oral polyethylene glycol electrolyte lavage (Adams et al, 1994; Cohen et al, 1994; Chia
et al, 1995; Golub et al, 1995; Hookey et al, 2004; Curran
and Plosker, 2004). Recently, however, a more complex triple regimen [senna syrup (sennoside B), Picolax
(sodium picosulphate), and Klean Prep (polyethylene glycol
3350)] appeared to be superior to Fleet Phospho-soda for
colonoscopy preparation, achieving better colonic cleansing (triple regimen 73%; Fleet phospho-soda 57%; P =
0.037) (Chilton et al, 2000). Subsequently, a comparison of
bowel cleansing efficacy in patients having colonoscopy, has
been made between the standard polyethylene glycol-electrolyte solution based on the GoLytely formulation (PEGEL1; Klean-Prep); a sulphate-free PEG-EL solution based
on the NuLytely formulation (PEG-EL2, Endofalk); and a
sodium phosphate preparation (NaP, Fleet Phospho-Soda).
Among 185 patients randomly assigned to the three therapies PEG-EL1 (Klean-Prep) was significantly superior to PEGEL2 (Endofalk) and NaP (Fleet Phospho-Soda) in achieving
effective cleansing of the entire colon prior to colonoscopy
(Ell et al, 2003).
In a comparison of patient preference between the techniques of computed tomography (CT) colonography and
conventional colonoscopy, bowel preparation was the feature of both techniques most disliked by the patients studied (Ristvedt et al, 2003). Lefere et al (2002) examined the
feasibility of detecting colonic polyps when a preparation
of reduced colonic cleansing had been employedfaecal
tagging. The technique of faecal tagging was better tolerated than conventional polyethylene glycol preparation and
also improved colonographic differentiation of polyps from
residual stool. In virtual magnetic resonance colonography, faecal tagging is employed by either making the stool
bright (Gd-based MR contrast agent) in conjunction with
Risk Management
83
84
Chapter 3
Perioperative Care
et al, 1982; Girard et al, 1984). There is no need to administer metoclopramide (Rhodes et al, 1978) but bisacodyl
reduces the fluid intake from 4 to 2 L, which is easier for
elderly patients to cope with, without compromising the
quality of preparation (Adams et al, 1994). The risk of
explosion is related only to the amount of faecal residue in
the colon and there is no disturbance in electrolyte balance
or acidosis (Ambrose et al, 1983b). The preparation is more
efficient than conventional preparation for colonoscopy
(Rhodes et al, 1977; Thomas et al, 1982; Ernstoff et al,
1983; DiPalma et al, 1984; Beck et al, 1985) but all forms
of gut lavage seem to be disappointing when used for barium enema examination (Skucas et al, 1976; Backran et al,
1977; King et al, 1979; Ernstoff et al, 1983). Completion
of a 4-L preparation is only achieved in 5065% of patients
and causes considerable nausea and distress to many
patients (Vanner et al, 1990; Marshall et al, 1993; Adams
et al, 1994; Chia et al, 1995; Golub et al, 1995).
Oral irrigation with electrolyte and polyethylene glycol
is preferred by most patients to conventional preparation
and nasogastric whole-bowel irrigation (Ambrose et al,
1983b). However, in our experience, compliance is much
higher with Picolax or sodium phosphate (Takada et al,
1989; Yoshioka et al, 1998). Outpatient compliance to the
polyethylene glycol electrolyte solution is variable. Many
elderly patients will not drink a sufficient volume to ensure
that the faecal effluent is completely clear. The technique
may also precipitate large bowel obstruction.
Purgation alone
Sodium picosulphate and magnesium
citrate (Picolax)
Sodium picosulphate with magnesium citrate (Picolax)
gives better results than either sennosides or mannitol
because the right colon is cleared better (Lee and Ferrando,
1984). In a randomised comparison of sodium picosulphate
with polyethylene glycol electrolyte lavage for colonoscopy,
picosulphate was significantly better, with fewer side effects
and better bowel cleansing (Regev et al, 1998). Picolax is
substantially more effective than preparation with enemas
and washouts (Roe et al, 1984). Tsang et al (1992) found
that Picolax was superior to a balanced oral electrolyte
solution (CP100) but inferior to sodium sulphate, which is
marginally less expensive. Clear fluids for 24 hours seems
essential to achieve an adequate bowel preparation.
Our practice has been to use Picolax exclusively, using
two sachets given 4 hours apart, 24 hours before operation, endoscopy or double contrast barium enema, followed
by clear fluids thereafter. Compliance is good and generally
a high-quality preparation is achieved. Dehydration was
common unless patients were given an intravenous
infusion or encouraged to take extra fluids (Takada et al,
1993; Barker et al, 1992).
Sodium phosphate
Sodium phosphate is marketed as Fleet phospho-soda. Its
advantage is that a much smaller volume is required compared with the polyethylene glycol electrolyte solutions: 45
mL of the highly osmotic cathartic is mixed with 90 mL of
water and taken twice (Chia et al, 1995). The only drawback to sodium phosphate is the small risk of hyperphos-
On-table preparation
Antegrade irrigation
Peroperative preparation is a method of ensuring that the
colon is empty prior to primary anastomosis. This procedure may be used either during an emergency operation
for bleeding, localised perforation or obstruction, or when
preoperative bowel preparation is unsatisfactory (Muir,
1968; Dudley et al, 1980).
Indications
Risk Management
Technique
Safety
It is important that mechanical bowel preparation is safe
and does not cause unnecessary discomfort or anxiety to
85
86
Chapter 3
Perioperative Care
b
Figure 3.5 On-table colonic lavage in progress. (a) An
electrolyte solution at body temperature is being irrigated
through an appendicostomy purse-string and solid faecal
residue is being irrigated from the colon proximal to the
tumour through the anaesthetic scavenger tubing which drains
into a plastic bag below the operating table. (b) Commercially
available device for achieving on-table colonic lavage to
achieve rapid volume irrigation. (c) Commercially available
technique for collecting effluent to minimize contamination
and to provide a method of venting.
Risk Management
87
88
Chapter 3
Perioperative Care
TABLE 3.13
group versus 2% in the no preparation group; other surgical site infections were 6% in the oral preparation group versus 5% in the no preparation group. Similarly, Ram et al
(2005) could find no advantage for mechanical bowel
preparation in a randomised controlled trial (RCT) of
patients undergoing elective colorectal surgery.
Zmora et al (2003a) recruited 415 patients into groups
for comparison of the effect of bowel preparation on postoperative sepsis: group A received 1 gallon of polyethylene
glycol 1216 hours before surgery (n = 187), group B
received no preoperative bowel cleansing (n = 193). The
groups were identical for demographics, indications for
surgery and type of surgery. After randomisation, 29
patients were excluded (18 APR, 11 proximal stoma).
Spillage of bowel content (Zmora et al, 2003b) was significantly more common in group A than group B. However,
there was no difference in the two groups in the rate
of postoperative wound infections, clinical anastomotic leaks
or intra-abdominal abscesses (Table 3.13). One patient in
each group died from sepsis related to an anastomotic
leak.
Slim et al (2004) conducted a meta-analysis of RCTs of
mechanical bowel preparation that identified 11 studies,
of which seven were felt to be suitable for inclusion. The
methodological quality of each trial was assessed for randomisation (Table 3.14), blinding and withdrawals or
dropouts; a trial was considered poor when it scored 2 or
less. The final meta-analysis for anastomotic leakage as the
outcome related to bowel preparation showed a negative
outcome for bowel preparation. Slim et al (2004) concluded that there was significantly higher incidence of
leaks in the preparation group than in the control group
(5.6% versus 3.2%; OR 1.74 (95% CI 1.05 to 2.90;
P = 0.032). They also concluded that wound infection was
higher after bowel preparation although not significantly
so (7.4% versus 5.7%; OR 1.33; 95% CI 0.882.03).
Bucher et al (2004), in a meta-analysis, examined seven
RCTs constituting 1297 patients undergoing elective colorectal surgery (642 who had received mechanical bowel
preparation and 655 who had not). Among all the RCTs
reviewed, anastomotic leak was significantly more frequent
in the mechanical bowel preparation group (35/642 =
5.6%), compared with the no mechanical bowel preparation group (18/655 = 2.8%) (OR 1.84; P = 0.03). By contrast, rates of intra-abdominal infection (3.7% for the
mechanical bowel preparation group versus 2.0% for the
no mechanical bowel preparation group), wound infection
Anastomotic leak
Intra-abdominal abscess
Wound infection
Total
After Zmora et al (2003a).
NS, not significant.
Group A: (n =187)
bowel
preparation
7 (3.7%)
2 (1.1%)
12 (5.4%)
19 (10.2%)
Group B: (n =193)
no bowel
preparation
4 (2.1%)
2 (1%)
11 (5.7%)
17 (8.8%)
P value
NS
NS
NS
NS
Risk Management
Quality
score
2
4
3
4
4
4
2
Leaks in prepared
patients
8/67
7/72
3/82
5/138
2/30
7/187
7/125
39/701
Leaks in
non-prepared patients
1/67
4/77
4/87
3/129
1/30
4/193
6/125
23/708
89
90
Chapter 3
Perioperative Care
ASA of > 2.
Operation classified as contaminated or dirty.
An operation lasting for a specific period of time (T hours)
where T is the 75th percentile of the duration of surgery
and depends on the surgical procedure being performed
(for large bowel surgery, T = 3 hours).
Risk Management
TABLE 3.15
Organ/space infection
Definition
Surgical site infection involving any part of the anatomy (i.e. organ/space) other than the
incision, opened or manipulated during the surgical procedure, that occurs within 30 days of
surgery if no implant is in place or within a year if an implant is in place and the infection
appears to be related to the surgical procedure and meets at least one of the following criteria:
Criterion 1
Purulent drainage from a drain that is placed through a stab wound into the organ/space
Criterion 2
The organ/space yields organisms from the culture of aseptically aspirated fluid or tissue or from
a swab with pus cells present
Criterion 3
An abscess or other evidence of infection involving the organ/space that is found by direct
examination during reoperation or by histopathological or radiological examination
Criterion 4
Diagnosis of an organ/space surgical site infection by an attending clinician
Important notes
1. Occasionally an organ/space infection drains through the incision. Such infection generally
does not require reoperation and is considered to be a complication of the incision and is
therefore classified as a deep incisional infection
2. Where doubt exists refer to the definitions of specific site of organ/space infection to
determine if the organ/space infection meets the definition
From Health Protection Agency (2004) http://www.hpa.org.uk/infections/topics_az/hai/menu.htm
91
92
Chapter 3
Perioperative Care
Colon
Colon
Colon
Colon
Risk
index
category
0
1
2
3
Number
of
hospitals
94
102
81
27
Pooled
mean
rate
4.0%
5.64%
8.55%
11.53%
Skin preparation
Most colorectal surgeons accept the need for antiseptic
skin preparation as well as antibiotic prophylaxis as protection against bowel contamination during resection
(Ambrose et al, 1983a; McDonald et al, 1984). Skin preparation should be performed with two applications of an
alcohol-based preparation, which should be given adequate time to dry between applications (Lilly and Lowbury,
1971; Lowbury and Lilly, 1973; Lowbury et al, 1974).
Hexachlorophane may cause hypersensitivity reactions
(Cruse and Foord, 1973); chlorhexidine or iodine solutions
in an alcohol base are usually preferred. In a Cochrane
systematic review (Edwards et al, 2004), six eligible RCTs
evaluating preoperative antiseptics were identified.
Significant heterogeneity meant that comparisons and the
results could not be pooled. In one study, infection rates
were significantly lower when skin was prepared using
chlorhexidine compared with iodine. There was, however,
no evidence of a benefit in four trials associated with the
use of iodophor impregnated drapes. The current view is
that there is insufficient research examining the effects of
preoperative skin antiseptics to allow conclusions to be
drawn regarding their effects on postoperative surgical
wound infections (Edwards et al, 2004).
Surgical technique
Simple matters, such as ensuring that division of the bowel
is the last event in a colonic resection, and the use of
occluding tapes and staples reduce the duration and the
extent of contamination (Keighley et al, 1996). Ensuring
that an adequate sucker is available when the bowel
is divided and the use of large gauze swabs soaked in an
antiseptic solution helps to minimise contamination (Rietz
Risk Management
Drainage
18/573 (3%)
11/522 (2%)
Non-drainage
25/567(4%)
7/519 (1%)
16/522 (3%)
19/519 (4%)
29/573 (5%)
24/542 (6%)
34/522 (7%)
28/567 (5%)
28/539 (5%)
32/519 (6%)
use of occlusive dressings was not associated with a reduction in wound infection rates but that larger trials were
probably required if a significant difference was to be
detected. Similarly, the need for wound dressing after 48
hours has not been supported by a reduced infection rate
in a comparison of two groups of 50 patients each (Meylan
and Tschantz, 2001).
Intraoperative antiseptics
Antiseptics can damage small blood vessels, collagen synthesis and rapidly dividing cells (Brennan et al, 1986).
Kuijpers (1985) questioned the wisdom of using povidoneiodine in patients with peritonitis, because this can
cause serious peritoneal damage. However, it can be useful
if there has been inadvertent faecal contamination
(Browne and Stoller, 1970; Gilmore et al, 1978b;
Ahrenholz and Simmons, 1979; Flint et al, 1979; Sindelar
and Mason, 1979). Most authorities believe that antiseptic lavage is unsafe if there is established inflammation, as
in faecal or purulent peritonitis (Lagarde et al, 1978;
McAvinchey et al, 1983). Neither continuous saline
nor antiseptic lavage influenced postoperative sepsis
in colorectal surgery (Hallerback and Andersson, 1986;
Leiboff and Soroff, 1987; Baker et al, 1994).
Intraluminal antiseptics may be used for rectal washouts
as they reduce the counts of luminal bacteria (Jones et al,
1976; Scammell et al, 1985). Povidoneiodine rectal
washout can be extended in a retrograde fashion to the
whole colon: 1 L reaches the caecum in 2 minutes (Mariani
et al, 2002). Although the use of povidoneiodine in this
fashion is associated with increased systemic iodine absorption, it appears that a single intraoperative bowel irrigation
with povidoneiodine may be performed with practically
no risk (Tsunoda et al, 2000).
Antiseptics have been applied to the wound at the end
of the operation to minimise the consequences of inadvertent contamination (Gilmore and Sanderson, 1975;
Gilmore, 1977; Stokes et al, 1977; Gilmore et al, 1978a;
Sindelar and Mason, 1979; Galle and Homersley, 1980; de
Jong et al, 1982). A more recent extension of this approach
has been the development of antiseptic wound ventilation
with a combination of CO2 and 95% ethanol (Persson et al,
2003). On filter disks, CO2 carrying vapour from a 95%
93
94
Chapter 3
Perioperative Care
Local warming
Systemic warming
All warmed patients
Non-warmed
P
n
138
139
277
139
Wound
infection rate
5 (4%)
8 (6%)
13 (5%)
19 (14%)
0.001
Topical antibiotics
Topical antibiotics have been explored but administration
is rarely advised in colorectal procedures (Nash and Hugh,
1967; Anderson et al, 1972; Evans and Pollock, 1973;
Stone and Hester, 1973; Evans et al, 1974; Holder, 1976;
Lord et al, 1977; Greenhall et al, 1979; Brumfitt and
Hamilton-Miller, 1980; Pitt et al, 1980; Pollock, 1981). In
intestinal surgery, topical cephradine was inferior to systemic antibiotic administration (Finch et al, 1979). The
combination of broad-spectrum systemic antibiotic cover
and topical agents conferred no benefit over intravenous
administration alone in colorectal surgery (Moesgaard
et al, 1988; Raahave et al, 1989). A recent meta-analysis
indicates that topical ampicillin versus no antibiotic prophylaxis in both clean contaminated wounds and contaminated wounds significantly reduces surgical wound
infection rates (clean contaminated wounds OR = 0.084;
95% CI 0.040.16; P < 0.0001; contaminated wounds
OR = 0.262; 95% CI 0.140.51; P < 0.0001). However,
topical ampicillin combined with systemic antibiotics
offers no reduction in surgical wound infection rates
over systemic antibiotics alone (Charalambous et al, 2003).
A recent Health Technology Assessment of antimicrobial
prophylaxis in colorectal surgery could find no additional
benefit in six trials that compared parenteral alone with
parenteral plus topical wound antibiotic prophylaxis
(Song and Glenny, 1998).
Intraincisional antibiotics
Antibiotics may be administered by injection into the subcutaneous tissues and the rectus muscle immediately prior
to laparotomy (Armstrong et al, 1982; Taylor et al, 1982;
Wound infection
ASEPSIS score
Solid food (days)
Skin staples out (days)
Length of stay (days)
From Greif et al (2000).
NS, not significant.
30% oxygen
(n = 250)
28 (11.2%)
59
4.4
10.4
11.9
80% oxygen
(n = 250)
13 (5.2%)
37
4.5
10.3
12.2
P
0.01
0.01
NS
NS
NS
Risk Management
Concentration (mg/L)
25
Cinc
20
15
Cclos
10
AUClurg
5
0
0
Time (hours)
95
96
Chapter 3
Perioperative Care
Risk Management
A few studies have compared oral against systemic antimicrobial prophylaxis. In three, oral administration was
inferior to systemic antibiotic cover (Keighley et al, 1979;
Weaver et al, 1986; Lau et al, 1988), whereas two studies
showed no difference (Aeberhard et al, 1979; Beggs et al,
1982). The combination of oral and systemic antibiotic
cover was shown to be superior to intravenous administration alone in three studies (Kaiser et al, 1983; Playforth
et al, 1988; Taylor and Lindsay, 1994), equivalent in one
study (Lau et al, 1988) and inferior in another (Coppa and
Eng, 1988).
Espin-Basany et al (2005) compared 300 elective
patients undergoing colorectal resection randomised to one
of the following three groups: group A received three doses
of oral antibiotic at the time of mechanical colon cleansing (1 g neomycin and 1 g metronidazole at 3.00 p.m.,
7.00 p.m. and 11.00 p.m.); group B received one dose of
oral antibiotic (1 g neomycin and 1 g metronidazole at
3.00 p.m.) and group C received no oral antibiotics. Not
only did oral antibiotics not confer any advantage in reducing wound sepsis (Table 3.20), but patient tolerance to oral
antibiotics, reflected as gastrointestinal symptoms at the
time of preoperative preparation for surgery (i.e. nausea,
vomiting), was significantly more common in patients with
combined treatment (group A) than in those who did not
receive oral antibiotics or received only one dose.
Influence on faecal flora
cephalosporins suppress faecal microflora with the emergence of Clostridium difficile (Ambrose et al, 1985), whereas
tinidazole, metronidazole and most of the penicillins
have little, if any, influence (Heimdahl and Nord, 1979;
Heimdahl et al, 1982; Kager et al, 1985).
Prophylactic regimens
The antibiotics chosen for prophylaxis should provide adequate serum concentrations for the duration of the operation. Some cephalosporins, penicillins and aminoglycosides
have extremely short half-lives. Therefore, for complex
colorectal procedures involving excessive blood loss or prolonged operation, repeated intraoperative antibiotic administration may be indicated (Burdon et al, 1985).
With the exception of a study with four major variables
and small numbers (McArdle et al, 1995) most now indicate that, provided antibiotics with an adequate half-life
are used for prophylaxis, single-dose cover is as effective as
prolonged antibiotic cover for 24 hours or even several days
(Higgens et al, 1980; Giercksky et al, 1982; Goransson
et al, 1984; Dipiro et al, 1986; Juul et al, 1987; Jensen et al,
1990; Rowe-Jones et al, 1990; Wittmann and Schein,
1996). Agents such as ceftriaxone, with a long serum halflife, have been particularly effective in large-bowel surgery
(Shepherd et al, 1986; Weaver et al, 1986; Morris, 1993;
Matikainen and Hiltunen, 1993). Song and Glenny (1998)
in a health technology assessment, examined seventeen
randomised trials comparing a single-dose regimen with a
multiple-dose regimen (one or two doses) using the same
antibiotic or combinations of antibiotics. None of these trials found a significant difference in postoperative surgical
wound infection between single dose and multiple dose
regimens.
Many studies have examined single and combined
antibiotic agent efficacy for prophylaxis in colorectal surgery (Morris et al, 1984; Cunliffe et al, 1985; Norwegian
Study Group, 1985; Roland et al, 1986; Bergman and
Solhaug, 1987). So far, single-agent, broad-spectrum
antibiotic cover does not seem to be sufficiently reliable
to be advised in colorectal surgery (Hares et al, 1981a;
de la Hunt and Karran, 1986; McCulloch et al, 1986; Tudor
et al, 1988; Walker et al, 1988; Hall et al, 1989;
Kingston et al, 1989; Taylor and Lindsay, 1994). A specific anaerobicide alone is inadequate for prophylaxis
Group A %
7
2
7
4
4
0
Group B %
8
2
13
4
3
1
Group C %
6
3
10
3
4
2
P value
0.858
0.368
97
98
Chapter 3
Perioperative Care
axone 6%, cefotaxime 18%, P < 0.05) but the cost of infection was the same (average cost ceftriaxone $994 s.d.
$1101, cefotaxime $878 $1318). For all other procedures, the frequency of wound infection was similar (ceftriaxone 8%, cefotaxime 10%) but the cost was less with
ceftriaxone (ceftriaxone $887 $1743, cefotaxime $2995
$6592; P < 0.05). Ceftriaxone decreased the frequency
but not the cost of chest and urinary infection (frequency ceftriaxone 6%, cefotaxime 11%; P < 0.02; cost ceftriaxone $1273 2338, cefotaxime $1615 4083).
Ceftriaxone decreased either the frequency or the cost of
different postoperative infections (Table 3.21). In the
future, the cost of infection after antibiotic prophylaxis may
both increase the discriminatory power of trials comparing
antibiotic effectiveness and provide a significant factor in
prophylactic regimen choice.
Methicillin-resistant Staphylococcus aureus
An unfortunate feature of all hospital medicine, including
colorectal surgical practice, is the increasing prevalence of
methicillin-resistant Staph. aureus (MRSA) (Figure 3.8),
which is now considered to be undergoing an epidemic
increase, hence the designation EMRSA for epidemic MRSA
strains (Leaper, 2004).
A retrospective cohort study at the Detroit Receiving
Hospital, between 1999 and 2001, of patients with Staph.
aureus bacteraemia compared outcomes associated with
MRSA isolates and methicillin-susceptible Staph. aureus
(MSSA; Lodise and McKinnon, 2005). Controlling for
confounding variables, patients with MRSA had a 1.5-fold
longer length of stay (19.1 versus 14.2 days; P = 0.005)
and a 2-fold increased cost of hospitalisation ($21 577 versus $11 668; P = 0.001) compared with MSSA. In addition, patients with MRSA were at increased risk of
infection-related death (Table 3.22).
Isolated strains of MRSA are numbered sequentially in
the UK, where three have dominated: EMRSA-1, which was
prevalent in the Thames regions in the 1980s and probably originating in Australia, and EMRSA-15 and EMRSA16, which are currently predominant in the UK and are
responsible for outbreaks elsewhere (Duckworth, 2003).
Cefotaxime
100
18 (18%)
878 ( 1368)
330 (04557)
P value
NS
< 0.05*
< 0.05
NS
Risk Management
THROMBOEMBOLISM PROPHYLAXIS
Patients at risk
35%
34%
45%
42%
46%
49%
43%
41%
MRSA
(n = 170)
52 (30.6 %)
MSSA
(n = 183) P value
28 (15.3%)
0.001
20.1
22 735
13.7
11 205
< 0.001
< 0.001
99
100
Chapter 3
Perioperative Care
Mechanical prophylaxis
Nicolaides et al (2001) reviewed the evidence for the efficacy of mechanical prophylaxis in patients undergoing
general surgical and urological procedures. When DVT was
assessed, by phlebography or fibrinogen uptake, a reduced
incidence of DVT was seen for both intermittent compression and the use of graduated elastic compression stockings. This review data from 13 studies of intermittent
pneumatic compression showed DVT formation in 7.7% of
776 patients compared with 24% of 835 control patients.
A pooled comparison for the prophylactic use of graduated
compression stockings demonstrated a DVT rate of 11% in
463 patients subjected to the intervention compared with
29% of the 446 control patients (Nicolaides et al, 2001).
In a Cochrane systematic review, Amaragiri and Lees
(2000) considered the outcomes of seven RCTs in which
graduated compression stockings were the sole form of prophylaxis in a treatment group of 536 patients. The use of
compression stockings was associated with a DVT rate of
15% (assessed by I125 uptake test) compared with 29% in the
491 control patients (Petos OR 0.36; 95% CI 0.260.49)
with an overall effect of favouring treatment with graduated
compression stockings (P < 0.00001). The authors also concluded that graduated compression stocking prophylaxis
was even more effective when combined with another prophylactic technique (Amaragiri and Lees, 2000).
The optimal length of stocking required to prevent DVT
was the subject of a randomised study by Howard et al
(2004). This study recruited patients from a variety of
surgical specialties: breast and oncology (73 patients), ENT
(13), gastrointestinal (122), neurosurgery (34), orthopaedic
(62), urology (58) and vascular venous surgery (14). The
efficacy of stocking length in reducing DVT formation was
assessed against a background of low-molecular-weight
heparin (LMWH) thromboprophylaxis. The authors found
that the Medi Thrombexin climax thigh-length stockings were significantly better at preventing postoperative
DVT than the knee-length stockings (2 versus 11; OR 0.18;
95% CI 0.040782; P = 0.026) (Howard et al, 2004).
An alternative method of mechanical prophylaxis for
postoperative DVT/PE is the use of intermittent pneumatic
compression of the legs. A sequential compression device
consists of a microprocessor allowing pressurised air (e.g.
45 mmHg) into segmental compartments secured around
the leg for a fixed period of time (e.g. 11 seconds) (Auguste
et al, 2004). Sequential devices produce a wave-like
milking effect to evacuate the leg veins. This compression
may exert its prophylactic effect on thromboembolism,
partly by preventing venous stasis and partly from enhancing fibrinolysis. In one study, intermittent pneumatic
compression applied for 120 minutes to 21 male, nonsmoking volunteers ranging in age from 19 to 47 years was
Heparin prophylaxis
Heparin is the dominant form of pharmacological prophylaxis against VTE in colorectal practice. About one-third of
an administered dose of heparin binds to antithrombin (AT)
and this fraction is responsible for most of its anticoagulant
effect (Hirsh et al, 2001). The heparinAT complex inactivates a number of coagulation enzymes, including thrombin factor (IIa) and factors Xa, IXa, XIa and XIIa. Of these,
thrombin and factor Xa are most responsive to inhibition
and human thrombin is about 10-fold more sensitive to
inhibition by the heparinAT complex than factor Xa (Hirsh
et al, 2001) (Table 3.24).
To inhibit thrombin, heparin must bind to both the
coagulation enzyme and AT, but binding to the enzyme is
less important for the inhibition of activated factor X (factor Xa). Molecules of heparin containing < 18 saccharides
do not bind simultaneously to thrombin and AT and are
therefore unable to catalyse thrombin inhibition. By contrast, very small heparin fragments containing the highaffinity pentasaccharide sequence catalyse inhibition of
factor Xa by AT. By inactivating thrombin, heparin not only
prevents fibrin formation but also inhibits thrombin-induced
activation of factor V and factor VIII. Unfractionated
heparin (UFH) and LMWH also induce secretion of the tissue factor pathway inhibitor by vascular endothelial cells.
This reduces procoagulant activity of tissue factor VIIa
complex and could contribute to the antithrombotic action
of heparin and LMWH (Hirsh et al, 2001).
The activated partial thromboplastin time (APTT) activity of heparin mainly reflects its antifactor IIa activity.
LMWH fractions prepared from standard commercialgrade heparin have progressively less effect on the APTT,
as they were reduced in molecular size, while still inhibiting activated factor X (factor Xa) (Hirsh et al, 2001). The
reduced antifactor IIa activity relative to antifactor Xa
activity of LMWH, combined with a better benefit-to-risk
Risk Management
TABLE 3.24
Effects
Binds to AT-III and catalyses
inactivation of factors IIa,
Xa, IXa, and XIIa
Binds to heparin cofactor II
and catalyses inactivation
of factor IIa
Binds to platelets
Comments
Major mechanism for anticoagulant effect,
produced by only one third of heparin molecules
(those containing the unique AT-III-binding
pentasaccharide)
Anticoagulant effect requires high concentrations
of heparin and occurs to the same degree
whether or not the heparin has high or low
affinity for AT-III
Inhibits platelet function and contributes to the
hemorrhagic effects of heparin. High-molecularweight fractions have greater effect than
low-molecular-weight fractions
TABLE 3.25
Preparation
Ardeparin
Dalteparin
Enoxaparin
Nadroparin
Reviparin
Tinzaparin
Mean molecular
weight
6000
6000
4200
4500
4000
4500
1.9
From Weitz (1997), copyright Massachusetts Medical Society. All rights reserved.
101
102
Chapter 3
Perioperative Care
No. of
patients
Double-blind
randomized
multicentre
Randomized
controlled
936
320
LMWH
versus
comparator
Enoxaparin
versus UFH
Once-daily
dose of
LMWH
40 mg s.c.
Enoxaparin
versus control*
40 mg s.c.
6.7 versus
1.8%
Efficacy
VTE: 9.4% in both groups
Proximal DVT: 2.8
versus 2.6%
DVT: 0 versus 3%
Risk Management
VTE prophylaxis protocols should be included in surgical unit and ward guidelines, clinical pathways and resident medical officer manuals. Regular audits should be
undertaken of the extent and quality of VTE prophylactic
measures. There should be documentation in the case
notes of the VTE risk assessment for each patient and any
prophylactic measures that are used, mechanical (graduated compression stockings, intermittent pneumatic
compression) as well as pharmacological prophylaxis with
unfractionated heparin or LMWH (Fletcher, 2002).
After discharge home, the surgical patient can still be
vulnerable to VTE (Kearon, 2003). In orthopaedic surgery,
particularly in patients undergoing hip surgery, there is a
growing interest in using extended anticoagulation
beyond that traditionally given in the postoperative period
using LMWH, oral anticoagulants, or newer agents such
as fondaparinux sodium. Most studies show a benefit to
extending anticoagulation without a considerable increase
in major bleeding (Blanchard and Ansell, 2005). Hull et al
(2001) examined studies of out of hospital VTE prophylaxis with LMWH in patients undergoing elective hip surgery. Systematic review of six studies showed that,
compared with placebo, extended out-of-hospital LMWH
prophylaxis decreased the frequency of all episodes of deep
venous thrombosis [placebo rate 150/666 patients
(22.5%); relative risk 0.41; 95% CI 0.320.54; P <
0.001], proximal venous thrombosis [placebo rate 76/678
patients (11.2%); relative risk 0.31; 95% CI 0.200.47; P <
0.001] and symptomatic venous thromboembolism
[placebo rate 36/862 patients (4.2%); relative risk 0.36;
95% CI 0.200.67; P = 0.001]. Major bleeding was rare,
occurring in only one patient in the placebo group (Hull
et al, 2001).
Bergqvist et al (2002) examined the role of extended outof-hospital LMWH prophylaxis in patients undergoing open,
elective, curative surgery for a malignant tumour of the
gastrointestinal tract (other than the oesophagus),
genitourinary tract, or female reproductive organs. All
patients received 40 mg enoxaparin once daily, with the first
dose given 1014 hours preoperatively, for 610 days. After
this open-treatment period, the patients were randomly
assigned to receive 40 mg subcutaneous enoxaparin or
placebo once daily for 1921 days. The mean duration of
double-blind therapy was 19.5 days in the placebo group
and 19.3 days in the enoxaparin group. During the doubleblind period (Bergqvist et al, 2002), the overall incidence of
venous thromboembolism was 8.4% (28/332). In the group
given 1 week of prophylaxis (placebo group), the incidence
was 12.0% (20/167); in the group given 4 weeks of prophylaxis, it was 4.8% (8/165) (P = 0.02). This corresponds
to a reduction in risk of 60% (95% CI 1082). Proximal
deep vein thrombosis was identified in three patients in the
placebo group and one in the enoxaparin group. Similar
results have been described in colorectal cancer patients.
Rasmussen (2003) investigated 117 patents having surgery
for malignant disease (colorectal cancer resection in the
large majority) 63 of whom had no further thromboprophylaxis on discharge and 53 being given 4 weeks of out
of hospital prophylaxis with dalteparin 5000 IU daily.
Prolonged thromboprophylaxis with daltaparin in this cancer population reduced the incidence of all DVT from 15.9%
103
104
Chapter 3
Perioperative Care
TABLE 3.27
Appropriate indication
Contraindication
to anticoagulation
in established
thromboembolic
disease
Potential indication
Failure of adequate anticoagulation
Pulmonary thromboembolectomy patients
Prophylaxis in high-risk trauma patients
Extensive free-floating iliofemoral thrombus
Thrombolysis of iliocaval thrombus
Unsubstantiated indication
Treatment of VTE in:
Cancer patients
COPD patients
Patients with poor cardiopulmonary reserve
Pregnant patients
Organ transplant patients
Patients with history of GI bleed
Prophylaxis in burn patients
Prophylaxis in bariatric surgery patients
Risk Management
105
106
Chapter 3
Perioperative Care
Coggins (2000) similarly demonstrated that in a hospital without a surgical HDU, at least 5% of the beds on a
general surgical ward are occupied by inappropriately
placed HDU patients. Moreover, the needs of such patients
has an impact on the number of observations made on the
more routine patientsthe mean of 5.1 observations every
24 hours falling to 3.8 every 24 hours in the presence of
an HDU patient (P < 0.02). Accordingly, in UK practice the
provision of surgical HDU has developed on an ad hoc basis
out of and alongside the ITU. Nehra et al (1994) proposed
that a 250 000-population UK district general hospital
would require a six-bed ITU and eight high-dependency
surgical beds in two separate but adjacent units, where
there will be a free interchange of skills at the different
levels of care.
Attempts to demonstrate that the introduction of a surgical HDU will reduce surgical mortality can be confounded
by other variables in a hospitals casemix. Thus, in one hospital the first 12 months of HDU utilisation was associated
with an increase in overall surgical mortality from 2.16%
to 3.2%; however, in the same 12 months there was a disproportionate increase in emergency admissions (27%)
and emergency out-of-hours operating (12%) (Davies et al,
1999). A more telling demonstration of surgical highdependency care on surgical outcomes is provided by a
study of 1363 patients undergoing a range of surgical procedures. Postoperatively, 349 were judged by the surgeon
and anaesthetist to require HDU provision but only 140
(42.3%) actually received HDU care. In the group of
patients that received optimal postoperative care, the mortality rate was 1.2%significantly better than the 3.1%
mortality rate observed among those not receiving the care
level requested (Turner et al, 1999).
Further evidence for a specific HDU effect on preventing postoperative morbidity comes from comparison of
outcomes between a surgical population managed on a
general ward in a hospital with no HDU and a similar surgical population managed in the HDU of a second hospital (Jones et al, 1999). Ideally, this study would have been
carried out in the same institution but the two groups
were very comparable in their physiological and operative severity scores. A surgical HDU association was seen
in reducing postoperative morbidity, specifically reducing
chest infections (25% versus 41%), prolonged hypotension (1% versus 14%) cardiac dysrhythmia (7% versus
13%) and wound infection (2% versus 17%) (Jones et al,
1999).
Step-down from ITU care is another function of surgical HDU care in the management of colorectal patients.
Papagrigoriadis et al (2004) described the hospital care
of 148 patients with diverticular disease. Of 982 hospital days, 94 were on an ICU and 68 were on a surgical HDU
(Papagrigoriadis et al, 2004). Boots and Lipman (2002)
describe the potential of every patient in the ICU to be at
some time classifiable as an HDU patient. In their view, only
if there is a need for monitoring for more than 1224
hours should a patient move from the ICU to the
HDU rather than being discharged to the ward. Other
advantages to surgical HDU care include:
Risk Management
100
90
Percentage of units
80
70
60
50
40
30
20
10
0
al
ur
d
pi
VP
lin
ito
in
on
ri
te
Ar
l
al
EC
e
tro
In
PA
be
as
pe
ch
a
Tr
ET
tu
PA
te
tio
ca
e
th
Ve
a
til
na
Re
Intervention
majority of these patients. Equal numbers of supraventricular and ventricular arrhythmias were detected, atrial
fibrillation being the most commonly detected abnormality. Therapeutic intervention (electrolyte correction and
anti-arrhythmic agents) was required in 23 patients. One
patient required DC shock for ventricular fibrillation. Seven
patients were transferred to the heart-care unit or intensive care unit to manage their cardiac problems. Two
patients died as a result of their cardiac problem and 27
were discharged home alive, three on long-term antiarrhythmic therapy.
The key to successful HDU care is multiprofessional
team care in which the surgical team, HDU nurses and
anaesthetic/intensivist colleagues assess patients for postoperative organ dysfunction and intervene early to prevent
organ failure. In this context, the following represent common HDU assessments and interventions.
250
200
150
100
50
0
199192
199293
Epidural
CVP
IV analgesia
199394
199495
Patient controlled
analgesia
Thrombolysis
Figure 3.10 Changes in epidural use in surgical highdependency unit admissions. From Coggins et al (1998).
107
108
Chapter 3
Perioperative Care
Assessment
Clinical examination/chest X-ray,
ABGs, ARDS
Interventions
Increase FiO2
CPAP
ITU referral
ABG, arterial blood gases; ARDS, acute respiratory distress syndrome; CPAP, continuous positive airway
pressure; ITU, intensive treatment unit.
Haemodynamic stability
Monitoring
Pulse rate
Blood pressure
Urine output
Assessment
Clinical examination
Observation trends
Interventions
Fluid bolus
Exclude haemorrhage
Dopamine
ITU referral
Assessment
Clinical examination
Respiratory effort
Interventions
Epidural adjustment
PCA
Analgesic requirements
Monitoring
Pain score
Cardiac arrhythmia
Monitoring
ECG trace
Assessment
Clinical examination
K+/Mg2+
Acidbase balance
Interventions
Correct electrolytes
ITU/cardiology consult
(anti-arrhythmic
drugs/DC shock)
It is inappropriate to discuss detailed preoperative assessment here and general references are given at the end of
the chapter. It is, however, sensible to list some of the
common problems that affect the management of anaesthesia and recovery, many of which not infrequently slip
through the net.
Cardiovascular disease
Hypertension
Risk Management
109
110
Chapter 3
Perioperative Care
Intraoperative techniques
For the well-prepared elective bowel resection, the requirements are abdominal muscle relaxation and lack of
response to surgical stimulae, preferably with contracted
intestines. This state of anaesthesia can be achieved by general or local techniques, or by a combination of both. In
the UK, the majority of colonic resections are done under
general anaesthesia using muscle relaxation. This gives a
smooth intraoperative course but can produce problems
during reversal and postoperatively (see below).
Increasingly, anaesthetists are combining general anaesthesia (to achieve unconsciousness) with some form of
regional blockade (to achieve analgesia), which can be carried into the postoperative period for pain relief. Patients
with a dense regional blockade who are awake during surgery are rarely seen in the UK, although it is not uncommon in some other European countries such as Sweden. In
certain instances (e.g. intestinal obstruction), the condition dictates specific techniques (e.g. rapid sequence induction with cricoid pressure in order to prevent aspiration
pneumonitis).
Risk Management
Epidural block
Because of the potential complications of epidural analgesia, all patients receiving it postoperatively should be
nursed in a suitable environment with ready access to
anaesthetic support. All catheters should be inspected after
removal and recorded as being intact. Although extradural
abscesses are rare, many anaesthetists are reluctant
to establish or continue with epidural analgesia in the
presence of systemic sepsis.
Other absolute contraindications to regional blockade
are local sepsis, patient refusal and the presence of a coagulopathy or therapeutic anticoagulation because of the risk
of epidural haematoma formation and subsequent neurological damage. There is controversy concerning the use of
these techniques in patients receiving prophylactic lowdose heparin or aspirin. There is no firm evidence that this
111
112
Chapter 3
Perioperative Care
Risk Management
Postoperative care
All patients recovering from general or regional anaesthesia should be admitted to a properly staffed and equipped
recovery room until they are in a satisfactory condition to
return to the general ward. There should be adequate
provision of high-dependency beds for patients undergoing major surgery or for those with significant intercurrent
disease, thereby allowing appropriate analgesia and
physiological support postoperatively. The use of highdependency beds allows proper intensive therapy facilities
to be used only for those patients requiring a higher level
of respiratory or cardiovascular support.
The major effects of anaesthesia on pulmonary gas
exchange in the postoperative period depend upon the site
of surgery. In the operative and immediate postoperative
period the functional residual capacity (FRC) is reduced
with alveolar gas trapping and there is an increased rightto-left shunt. The cause is unknown but it can produce a
fall in PaO2 of up to 30 mmHg (4.0 kPa) when breathing
air compared with the preoperative level. It is easily corrected by giving 3040% oxygen through a facemask. After
the first hour or two most patients reverse these changes
and effectively return to their normal preoperative state.
However, when patients with previously healthy lungs
There is a tremendous variability in individual requirements for postoperative analgesia. This is related to the site
of surgery, pharmacokinetic and pharmacodynamic variability, the psychological make-up of the patient and the
expectations of the ward staff. Regular recording of pain
postoperatively allows proper assessment and audit of the
problem and may, in itself, improve the administration of
analgesia (Gould et al, 1992). Recording may take the form
of a visual analogue scale or a simple scoring system. It is
preferable that the pain scores are recorded on the same
sheet as a sedation score and other routine postoperative
observations including respiratory rate, pulse and blood
pressure. Acute pain services are well established in many
hospitals and are instrumental in education, audit and
research and promoting safety.
The several ways in which postoperative pain can be
managed are described briefly below.
Oral analgesia
Oral analgesia for minor procedures may include paracetamol, codeine and tramadol. The latter is associated
with less constipation than codeine. Non-steroidal antiinflammatory drugs are useful for relieving the pain of
minor surgery and may also be used after major surgery
for their morphine sparing effect. Side-effects may include
renal dysfunction, bronchospasm and peptic ulceration.
Recent clinical guidelines on their use have been
113
114
Chapter 3
Perioperative Care
Only spinal opioids are relevant to postoperative pain control because local anaesthetics are short acting and spinal
blocks cannot be topped up. Spinal opioid receptors exist,
probably in the substantia gelatinosa, and their action is
thought to be presynaptic, reducing the release of substance P from the first-order pain neurons. Analgesia from
intrathecal morphine typically lasts for 24 hours and the
major danger is respiratory depression, which may not
occur maximally for several hours. Some of the complications of spinal anaesthesia have been given above in the
section on subarachnoid (spinal) block. Careful monitoring of respiration is essential after the administration of
spinal opioids. The side-effects of spinal opioids are similar
to those of epidural opioids.
Epidural techniques
Risk Management
A variety of drugs is available for prophylaxis and treatment. These act at different receptor sites and a combination of agents may be considered appropriate in high risk
patients. Agents available include the phenothiazines (e.g.
prochlorperazine), the butyrophenones (e.g. droperidol),
antihistamines (e.g. cyclizine), 5-hydroxytryptamine antagonists (e.g. ondansetron) and dexamethasone. Significant
side effects may occur with some of these agents.
Metoclopramide has limited efficacy for PONV. There
is good evidence that acupuncture may also be a useful
treatment modality.
Assessments
In the acute-care setting (Huckleberry, 2004), history of
weight loss from the patient, relatives or care-giver is the
basis of most nutritional assessments. As a rule of thumb,
patients weighing less than 70% of their ideal weight or
less than 80% of their usual weight are considered severely
malnourished. However, the accuracy of determining
weight loss by history alone has been questioned
(Jeejeebhoy, 2000): 33% of patients with weight loss being
missed and 25% of those with stable weight being wrongly
diagnosed as having lost weight. Aspects of physical examination may also be useful (Hammond, 1999) in assessing
nutritional status. Anthropometry includes triceps and
subscapular skinfold thicknesses, which provides an index
of body fat, and mid-arm muscle circumference, which
gives a measure of muscle mass. Although these measurements seem to be useful in population studies, their reliability in individual patients is less clear (Jeejeebhoy, 2000).
A valuable tool of bedside nutritional assessment is the
technique of subjective global assessment (SGA; Jeejeebhoy,
2000). The history used in the SGA determines:
115
116
Chapter 3
Perioperative Care
TABLE 3.28
Well nourished
No history of weight loss
No change in dietary intake
No physical findings
associated with
malnutrition
Improving findings of
malnutrition (recent
weight gain)
Moderately malnourished
History of decreased dietary intake
Weight loss (unintentional) of 5% to
10% of usual body weight
Mild signs of malnutrition on
physical examination:
Loss of subcutaneous fat
Muscle wasting
Severely malnourished
History of decreased dietary intake
Weight loss (unintentional) > 10% of usual body
weight
Severe signs of malnutrition on physical
examination:
Loss of subcutaneous fat
Muscle wasting
% ideal
body weight
8090%
7079%
< 70%
% usual
body weight
9095%
8089%
< 80%
BMI kg/m2
1718.5
1617
< 16
n
59
140
106
221
526
17.5
17.622.5
22.627.5
27.632.5 32.637.5
1/1
2/4
5/11
6/13
3/4
3/6
4/16
8/27
6/33
1/1
3/4
8/11
8/17
6/32
2/7
6/14
4/19
7/40
9/54
7/13 (54%) 12/24 (50%) 18/50 (36%) 28/95 (29%) 27/132 (20%)
37.642.5
6/25
7/46
4/30
2/68
19/169 (11%)
> 42.5
1/5
2/8
1/11
0/19
4/43 (9%)
Although albumin concentration correlates with outcomes it is not a good indicator of nutritional status per se
(Jeejeebhoy, 2000). This is because several processes control plasma albumin concentration, including the absolute
rate of albumin synthesis, the fractional catabolic rate
(FCR), albumin distribution between the vascular and
extravascular compartments, and exogenous loss of albumin. Thus the rate of albumin synthesis is affected by both
nutrition and inflammation, given that albumin is a negative acute-phase protein (Don and Kaysen, 2004).
Prealbumin has been proposed as a visceral protein that
is responsive to nutritional changes. However, it is also
influenced by several disease-related factors, making it
unreliable as an index of nutritional status in patients
(Jeejeebhoy, 2000).
Risk Management
Outside London
Small Trust
Medium-sized Trust
Large Trust
6.56
5.91
5.46
London
7.64
From Audit Commission (2001).
117
118
Chapter 3
Perioperative Care
TABLE 3.32
DEVICES
Procedure
Specific
than amino acids, hence these patients often receive peptide-based formulas. Lipids provide a concentrated source
of calories in the form of long-chain triacylglycerols derived
from vegetable oils. They are high-energy compounds that
contain approximately three times the amount of calories
as carbohydrates (9 kcal/g versus 3.4 kcal/g, respectively).
Typically, the total lipid content in formulas is limited to
30% of the total volume. A host of enteral formulas exist.
Table 3.33 lists important features that can be used for the
selection and administration of enteral feeding products
(Lipman, 2004).
Immunonutrients are defined as nutrients that provide specific benefits to the immune system, and include
glutamine, arginine, long-chain n-3 polyunsaturated fatty
acids (PUFAs) and nucleotides (Moskovitz and Kim,
2004):
Migration 12.516%
Dislodgement 2541%
Tube breakage 1120%
Tube occlusion 920%
PEG
Aspiration 0.31%
Haemorrhage 1%
Other viscous injury 0.51.8%
Transient pneumoperitoneum 4056%
Prolonged ileus 3%
Site infection 5.430%
Excessive leakage 12%
Buried bumper up to 21.8%
GI bleeding 0.61.2%
Inadvertent extubation 1.64.4%
Risk Management
TABLE 3.33
Water
Sufficient
free water
(1 kcal/cc
formulas) vs
concentrated
formulas with
free water
removed
Origin
Blenderised
whole food
vs defined
nutrient
substrates
Macronutrient content
Intact protein vs amino
acids and/or peptides
Complex carbohydrates
vs simple sugars
Normal fat content
vs reduced fat
medium-chain
triglycerides
Lactose-free
Added substrates
Soluble fibre
Immune-enhancing
nutrients: omega-3
fatty acids, RNA,
arginine, glutamine
Modules of protein,
carbohydrate or fat
can be added before
administration to
increase protein or
energy content
Disease specific
Liver
Pulmonary
Renal
Diabetes
Critical care
a reduction in infection rate: lower incidence of abdominal abscesses (OR 0.26; 95% CI 0.120.55; P = 0.005),
nosocomial pneumonia (OR 0.54; 95% CI 0.350.84;
P = 0.007) and bacteraemia (OR 0.45; 95% CI
0.350.84; P = 0.0002)
On this basis, Montejo et al (2003) concluded that the evidence supported a grade B recommendation for the use of
immunonutrient enteral feed in ICU patients.
Garcia-de-Lorenzo et al (2003) described glutamineenriched diets as being associated with good overall tolerance,
improvement of immunologic aspects in multiple trauma
patients, cost reduction in critically ill patients and improvement of mucositis in postchemotherapy patients (grade B
recommendations). However, several studies reviewed by
Heyland and Samis (2003), with the exception of Galban
et al (2000), indicated that septic critical care patients randomised to immunonutrition fared less well than patients
receiving standard enteral nutrition or parenteral nutrition (Table 3.34). Thus, Bertolini et al (2003) studied 237
patients randomised by 33 ICUs between November 1999
and April 2001, 39 of whom had severe sepsis. Of these 39
patients with severe sepsis, 21 were randomised to receive
either TPN (59% carbohydrate, 23% fat, 18% protein,
1.2 kcal/mL) and 18 were randomised to an enteral nutrition formula that included L-arginine, omega-3 fatty acids,
vitamin E, beta carotene, zinc and selenium (55% carbohydrate, 25% fat, 21% protein, 1.3 kcal/mL). The ICU mortality of the group receiving the enteral immunonutrients
(44%) was significantly higher than the group assigned
parenteral nutrition (14%). Heyland and Samis (2003)
speculate that the immune-modulating nutrient (or combination of nutrients) responsible for the excess harm
observed, in septic patients in these studies is probably arginine. Arginine supplementation is capable of promoting an
increase in nitric oxide production, which may have
an adverse effect on critically ill patients with sepsis.
Heyland and Samis (2003) therefore recommend more
study of arginine supplementation before it is routinely
incorporated into immunonutrient regimens.
Kieft et al (2005) conducted the largest randomised,
controlled trial of immunonutrition in a general ICU
119
120
Chapter 3
Perioperative Care
TABLE 3.34
Control group
4/45 (8.9%),
8/83 (9.6%)
Experimental
11/44 (25%)
20/87 (23%)
P value
0.051
0.03
28/87 (32.2%)
3/21 (14.3%)
17/89 (19.1%0
8/18 (44.4%)
0.05
0.039
Impact
L-arginine, omega-3 fatty acids,
vitamins A and E, beta carotene
Impact
L-arginine, omega-3 fatty acids, vitamin E,
beta carotene, zinc, selenium
complications. The authors concluded that the use of preoperative TPN should be limited to patients who are
severely malnourished unless there are other specific
indications.
Heyland et al (2001) conducted a meta-analysis of 27
papers that met their inclusion criteria. Overall, 2907
patients were randomised to comparisons of TPN against
standard care (oral diet or intravenous dextrose solution).
Aggregation of the results of these trials showed no effect
on mortality (RR = 0.97; 95% CI 0.751.24). However,
TPN was associated with a reduction in complication rates
(RR = 0.081; 95% CI 0.651.01, P = 0.06). Comparison
was made between trials that only included malnourished
patients with the other available trials. TPN was again not
associated with any difference in mortality in either studies
of malnourished or normally nourished patients. However,
TPN was associated with a significant reduction in complication rates in the trials that contained overtly malnourished patients (RR = 0.52; 95% CI 0.300.91). The authors
(Heyland et al, 2001) concluded that although methodology and year of publication might influence the metaanalysis findings, TPN appears to reduce the complication
rate in surgical patients but not the death rate of this group.
Nehra et al (1999) described their indications for parenteral nutrition in 100 consecutive patients. Characteristics
of this patient population included mean weight (118
29% of ideal), body mass index (25 6 kg/m2) and serum
albumin (28 7 g/L). The most common specific reasons
identified for initiating TPN rather than enteral nutrition
were ileus (25%), an underlying acidbase or electrolyte/
mineral disorder requiring correction (13%) and the convenience of TPN because a central venous catheter was in
place (12%). Jones (2003) describes three clinical patterns
of intestinal failure which may require parenteral support:
Risk Management
Endocarditis is a particularly feared complication of central-line access and may require repeated echocardiography (Leinhardt et al, 1992) to confirm the diagnosis.
Fungal as well as bacterial infection may be implicated in
the valvular lesions (Schelenz and Gransden, 2003).
Sutton et al (2005) introduced a clinical nurse specialist to maintain protocol standards for parenteral nutrition
venous catheters. The protocols included care of the exit
site (exit site from the subcutaneous tunnel), sprayed with
Betadine Powder Spray (Seton Healthcare plc, UK), dressed
with Mepore (Smith and Nephew plc, UK) and covered
with an Opsite dressing (Smith and Nephew plc, UK) and
the use of designated nursing staff to commence TPN infusions. Designated nurses were required to attend a study
day and pass a practical assessment dealing with aseptic
Year 0
(n = 56)
5.2
Year 1
(n = 54)
3.7
9.2
5.5
Year 2
(n = 49)
2
4
4
Year 3
(n = 34)
2.9
0
0
Year 4
(n = 40)
2.3
0
0
121
122
Chapter 3
Perioperative Care
Increased infectious complications for parenteral nutrition reported in six trials for which the relative risk for
enteral nutrition was 0.61. By contrast, there was no
significant difference in mortality or in length of stay.
Early enteral nutrition showed a trend toward reduced
mortality or infectious complications without statistical
significance.
Arginine supplementation in enteral nutrition did not
influence mortality or infections.
Glutamine supplementation resulted in heterogeneous
findings with reduced complications in some, but not
other, studies.
Enteral nutrition in the semirecumbent position significantly reduced the incidence of pneumonia in one
study.
Risk Management
TABLE 3.36
Equation
Harris and Benedict
Schofield
Subset of subjects
Males
Females
Males, 3060 years
Females, 3060 years
Males, over 60 years
Females, over 60 years
Formula
BMR (kJ/day) = (57.5 W) + (20.9 H) (28.3 A) + 278
BMR (kJ/day) = (40.0 W) + (7.7 H) (19.6 A) + 2741
BMR (MJ/day) = (0.048 W) + 3.653
BMR (MJ/day) = (0.034 W) + 3.538
BMR (MJ/day) = (0.049 W) + 2.459
BMR (MJ/day) = (0.038 W) + 2.755
Postoperative mobilisation and oral intake followed a welldefined nursing care program (Table 3.37).
The colonic resections (Basse et al, 2000) included 23
right-sided hemicolectomies, two resections of the transverse colon, 34 sigmoid resections or left hemicolectomies
and one subtotal colectomy. Median duration of surgery
was 120 minutes (range 70360). Median intraoperative
blood loss was 100 mL (range 502450 mL). Underlying
colonic disease was cancer in 42 patients (Dukes A in
four patients, Dukes B in 22, Dukes C in 11 and Dukes
D in five), lymphoma in one patient and benign colonic
diseases in 17 patients. Overall, normal gastrointestinal
function (defecation) occurred within 48 hours in 57
patients and the median hospital stay was 2 days. There
were no cardiopulmonary complications. The readmission rate was 15%, including two patients with anastomotic dehiscence (one treated conservatively, one with
colostomy); other readmissions required only short-term
observation.
In a similar study, Delaney et al (2001) subjected 60 consecutive patients [median age 44.5 (range 1370) years]
undergoing major procedures to a fast track protocol (early
diet and early ambulation; defined discharge criteria) over
a 6-week period. Nasogastric tubes and epidural anaesthesia were not used. Patients participated in a protocol of early
diet and early ambulation, and were discharged after meeting defined criteria. Fifty-eight patients (97%) were deemed
suitable for the fast track approach at the time of surgery
and stayed for a mean (S.D.) of 4.3 (1.6) days after operation. Three patients (5%) required a nasogastric tube for
vomiting. No readmissions were directly attributable to fast
track failure, although four patients (7%) were readmitted
within 30 days of operation for other reasons. Eight poorly
compliant patients stayed for 5.1 (1.1) days (P = 0.02
versus compliant patients).
A comparison of outcomes after colonic resection and
conventional care with fast-track multimodal rehabilitation was carried out by Basse et al (2004). However, the
123
124
Chapter 3
Perioperative Care
two populations compared were treated in separate hospitals: 130 consecutive patients receiving conventional
care (group 1) in one hospital were compared with 130
consecutive patients receiving multimodal, fast-track
rehabilitation (group 2) in another hospital. Median age
was 74 years (group 1) and 72 years (group 2) and the
ASA score was significantly higher in group 2 (P < 0.05).
Defecation occurred on day 4.5 in group 1 and day 2 in
group 2 (P < 0.05). Median hospital stay was 8 days in
group 1 and 2 days in group 2 (P < 0.05). The overall
complication rate (35 patients) was lower in group 2
(P < 0.05), especially cardiopulmonary complications
(five patients; P < 0.01). Readmission was necessary in
12% of cases in group 1 and 20% in group 2 (P > 0.05)
(Basse et al, 2004).
Nygren et al (2005) performed a comparative study of
outcomes from four European units practising conven-
Risk Management
Total
451
10 (2)
49 (11)
33 (7)
DK
118
6 (5)
26 (22)
8 (7)
2 (1)
NL
76
2 (3)
6 (8)*
7 (9)
8 (6)*
NO
61
1 (2)
10 (16)
8 (13)
7 (3)*
UK
87
1 (1)
2 (2)*
3 (3)
9 (6)*
SE
109
0 (0)
5 (5)*
7 (6)
7 (5)*
Audit of compliance/
outcomes
Perioperative
oral nutrition
Preadmission
counselling
No bowel preparation
Fluid and
carbohydrate-loading/
on fasting
Early removal
of catheters
No premedication
Stimulation
of gut motility
ERAS
No nasogastric tubes
Prevention of nausea
and vomiting
Mid-thoracic epidural
anaesthesia/analgesia
Non-opiate oral
analgesics/NSAIDs
Short-acting
anaesthetic agent
Routine mobilisation
care pathway
Warm air body
heating in theatre
Short incisions,
no drains
Avoidance of sodium/
fluid overload
125
126
Chapter 3
Perioperative Care
Consensus 17: patients should be nursed in an environment that encourages independence and mobilisation.
A care plan that facilitates patients being out of bed for
2 hours on the day of surgery and 6 hours thereafter is
recommended.
Consensus 18: planning the discharge process should
begin when the patient attends for preadmission
counselling. Defined discharge criteria should be
followed:
good pain control with oral analgesia
taking solid food, no intravenous fluids
independently mobile or same level as prior to admission
all of the above and willing to go home.
Consensus 19: surgical units undertaking an enhanced
recovery programme must be restructured to provide
adequate follow-up and continuity of care. An enhanced
recovery programme should only be initiated once there
is a clear pathway established for the prompt and safe
readmission of the 13% of patients who will experience
an anastomotic leak (or other major complications) at
home.
Consensus 20: audit is an inherent and essential component of every enhanced recovery programme.
REFERENCES
Adams WJ, Meagher AP, Lubowski DZ & King DW (1994)
Bisacodyl reduces the volume of polyethylene glycol solution
required for bowel preparation. Dis Colon Rectum 37:
229234.
Adler M, Quenon M, Even-Adin D et al (1984) Whole gut lavage for
colonoscopy: a comparison between two solutions. Gastrointest
Endosc 30: 65.
Aeberhard P, Berger J & Casey P (1979) A comparison of oral bowel
preparation and intravenous chemotherapy given at the time of
operation. R Soc Med Int Cong Symp Ser 18: 173177.
Afridi SA, Barthel JS, King PD et al (1995) Prospective randomized
trial comparing a new sodium phosphatebisacodyl regimen with
conventional PEDES lavage for outpatient colonoscopy preparation.
Gastrointest Endosc 41: 485489.
Ahrendt GM, Gardner K & Barbul A (1994) Loss of colonic structural
collagen impairs healing during intra-abdominal sepsis. Arch Surg
129: 11791183.
Ahrendt GM, Tantry US & Barbul A (1996) Intra-abdominal sepsis
impairs colonic reparative collagen synthesis. Am J Surg 171:
102108.
Ahrenholz DH & Simmons RL (1979) Povidoneiodine in peritonitis: I.
Adverse effects of local instillation in experimental E. coli
peritonitis. J Surg Res 26: 458463.
Aitkenhead AR, Gilmour DG, Hothershall AP & Ledingham IMcA
(1980) Effects of sub-arachnoid spinal nerve block and arterial
PCO2 on colon blood flow in the dog. Br J Anaesth 52: 10711077.
References
Basse L, Thorbol J.E., Lossl K & Kehlet H (2004) Colonic surgery with
accelerated rehabilitation or conventional care, Dis Colon Rectum
47(3): 271277.
Bates T, Siller G, Crathern BC et al (1989) Timing of prophylactic
antibiotics in abdominal surgery: trial of a pre-operative versus an
intra-operative first dose. Br J Surg 76: 5256.
Batra GS, Molyneux J & Scott NA (2001) Colorectal patients and
cardiac arrhythmias detected on the surgical high dependency
unit. Ann R Coll Surg Engl 83(3): 174176.
Bauer J, Reeves MM, Capra S (2004) The agreement between
measured and predicted resting energy expenditure in patients
with pancreatic cancer: a pilot study. JOP 5(1): 3240.
Bauersachs RM (2005) Fondaparinux: an update on new study
results. Eur J Clin Invest 35: 2732.
Beck DE, Hartford FJ & DiPalma JA (1985) Comparison of cleansing
methods in preparation for colonic surgery. Dis Colon Rectum 28:
491495.
Beggs FD, Jobanputra RS & Holmes JT (1982) A comparison of
intravenous and oral metronidazole as prophylactic in colorectal
surgery. Br J Surg 69: 226227.
Bell CMA & Lewis CB (1968) Effect of neostigmine on integrity of
ileorectal anastomosis. Br Med J 3: 587588.
Bennett-Guerrero E, Hyam JA, Shaefi S et al (2003) Comparison of
P-POSSUM risk-adjusted mortality rates after surgery
between patients in the USA and the UK. Br J Surg 90(12):
15931598.
Bergman L & Solhaug JH (1987) Single-dose chemoprophylaxis in
elective colorectal surgery. A comparison between doxycycline plus
metronidazole and doxycycline. Ann Surg 205: 7782.
Bergqvist D (2004) Low molecular weight heparin for the prevention
of venous thromboembolism after abdominal surgery. Br J Surg
91(8): 965974.
Bergqvist D, Agnelli G, Cohen AT et al; the Enoxacan II investigators
(2002) Duration of prophylaxis against venous thromboembolism
with enoxaparin after surgery for cancer. N Engl J Med 346(13):
975980.
Berry MA & DiPalma JA (1994) Review article: orthograde gut lavage
for colonoscopy. Aliment Pharmacol Ther 8: 391395.
Bertolini G, Iapichino G, Radrizzani D et al (2003) Early enteral
immunonutrition in patients with severe sepsis: results of an
interim analysis of a randomized multicentre clinical trial. Intensive
Care Med 29(5): 834840.
Bigarde MA, Gaucher P & Lassalle C (1979) Fatal colonic explosion
during colonoscopic polypectomy. Gastroenterology 77:
13071310.
Bigler D, Hjortso N-C & Kehlet H (1985) Disruption of colonic
anastomosis during continuous epidural analgesia. An early postoperative complication. Anaesthesia 40: 278280.
Binder HJ (1977) Pharmacology of laxatives. Ann Rev Pharmacol
Toxicol 17: 355367.
Birnbaum D, Ben-Menachem J & Schwartz A (1970) The influence of
oral diazepam on gastrointestinal motility. Am J Proctol 21:
263267.
Bissett L (2005) Controlling the risk of MRSA infection: screening and
isolating patients. Br J Nurs 14(7): 386390.
Bistrian BR & Babineau T (1998) Optimal protein intake in critical
illness? Crit Care Med 26(9): 14761477.
Blanchard E & Ansell J (2005) Extended anticoagulation therapy
for the primary and secondary prevention of venous thromboembolism. Drugs 65(3): 303311.
Boots R & Lipman J (2002) High dependency units: issues to consider
in their planning. Anaesth Intensive Care 30(3): 348354.
Borly L, Wille-Jrgensen P & Rasmussen MS (2005) Systematic review
of thromboprophylaxis in colorectal surgery an update. Colorectal
Dis 7(2): 122127.
Brandjes DP, Buller HR, Heijboer H et al (1997) Randomised trial of
effect of compression stockings in patients with symptomatic
proximal-vein thrombosis. Lancet 349(9054): 759762.
127
128
Chapter 3
Perioperative Care
References
129
130
Chapter 3
Perioperative Care
References
131
132
Chapter 3
Perioperative Care
Hoppener MR & Buller HR (2005) New anticoagulants and thromboprophylaxis. Br J Surg 92(3): 259261.
Hotokezaka M, Adams RB, Miller AD et al (1996) Laparoscopic
percutaneous jejunostomy for long term enteral access. Surg Endosc
10(10): 10081011.
Howard A, Zaccagnini D, Ellis M et al (2004) Randomized clinical trial
of low molecular weight heparin with thigh-length or knee-length
antiembolism stockings for patients undergoing surgery. Br J Surg
91(7): 842847.
Huckleberry Y (2004) Nutritional support and the surgical patient.
Am J Health Syst Pharm 61(7): 671682.
Huddy SPJ, Rayter Z, Webber PP & Southam JA (1990) Preparation of
the bowel before elective surgery using a polyethylene glycol
solution at home and in hospital compared with conventional
preparation using magnesium sulphate. J Coll Surg Edinb 35:
1620.
Hughes ESR (1966) Mortality of acute bowel obstruction. Br J Surg
53: 593594.
Hughes ESR (1972) Asepsis in large-bowel surgery. Ann R Coll Surg
Engl 51: 347356.
Hughes ESR, McDermott FT, Polglase AL et al (1982) Sepsis and
asepsis in large bowel cancer surgery. World J Surg 6: 160165.
Hull RD, Pineo GF, Stein PD et al (2001) Extended out-of-hospital
low-molecular-weight heparin prophylaxis against deep venous
thrombosis in patients after elective hip arthroplasty: a systematic
review. Ann Intern Med 135(10): 858869.
Hunt TK, Hawley PR, Hale J et al (1980) Colonic repair; the
collagenous equilibrium. In Hunt TK (ed.) Wound healing and
wound infection: theory and surgical practice, p 153. New York:
Appleton-Century-Crofts.
Hunter JM (1996) Is it always necessary to antagonise neuromuscular
block? Do children differ from adults? Br J Anaesth 77: 707709.
Ikeda T, Tayefeh F, Sessler DI et al (1998) Local radiant heating
increases subcutaneous oxygen tension. Am J Surg 175(1): 3337.
Irvin TT & Greaney MG (1977) The treatment of colonic cancer presenting with intestinal obstruction. Br J Surg 64: 741744.
Irvin TT, Goligher JC & Johnston D (1975) A controlled trial of three
different methods of perineal wound management following
excision of the rectum. Br J Surg 62: 287291.
Irving AD & Scrimgeour D (1987) Mechanical bowel preparation for
colonic resection and anastomosis. Br J Surg 74: 580581.
Ivarsson L, Darle N, Kewenter JG et al (1982) Short-term systemic
prophylaxis with cefoxitin and doxycycline in colorectal surgery.
Am J Surg 144: 257261.
Jacobs DG & Sing RF (2003) The role of vena caval filters in the
management of venous thromboembolism. Am Surg 69(8):
635642.
Jansen JO, OKelly TJ, Krukowski ZH & Keenan RA (2002) Right
hemicolectomy: mechanical bowel preparation is not required.
J R Coll Surg Edinb 47(3): 557560.
Jauch R, Hawkwitz R, Beschke K & Pelzer H (1975) Bis-(p-hydroxyphenyl)-pyridyl-2-methane: the common laxative principle of
bisacodyl and sodium sulphate. Arzneimittelforschung 25:
17961800.
Jeejeebhoy KN (2000) Nutritional assessment. Nutrition 16(78):
585590.
Jenkins TPN (1976) The burst abdominal wound: a mechanical
approach. Br J Surg 63: 873.
Jennings WC, Wood CD & Guernsey JM (1982) Continuous
postoperative lavage in the treatment of peritoneal sepsis. Dis Colon
Rectum 25: 641643.
Jensen LS, Anderson A, Fristrup SC et al (1990) Comparison of one
dose versus three doses of prophylactic antibiotics, and the
influence of blood transfusion, on infectious complications in acute
and elective colorectal surgery. Br J Surg 77: 513518.
Jepsen S, Klaerke A, Nielsen PH & Simonsen O (1986) Negative effect
of metoclopramide in post-operative adynamic ileus. A prospective,
randomised, double blind study. Br J Surg 73: 290291.
References
133
134
Chapter 3
Perioperative Care
Meylan G & Tschantz P (2001) Surgical wounds with or without dressings. Prospective comparative study. Ann Chir 126(5): 459462.
Miettinen RP, Laitinen ST, Makela JT & Paakkonen ME (2000) Bowel
preparation with oral polyethylene glycol electrolyte solution vs. no
preparation in elective open colorectal surgery: prospective,
randomized study. Dis Colon Rectum 43(5): 669675.
Mikal S (1965) Metabolic effects of preoperative intestinal
preparation. Am J Proctol 16: 437442.
Miller RE (1975) The cleansing enema. Radiology 117: 483485.
Minervini S, Alexander-Williams J, Donovan I et al (1980a)
Comparison of three methods of whole-bowel irrigation. Am J Surg
140: 399402.
Minervini S, Bentley S, Youngs D et al (1980b) Prophylactic saline
peritoneal lavage in elective colorectal operations. Dis Colon Rectum
23: 392394.
Moesgaard F, Lykkegaard & Nielsen M (1988) Failure of topically
applied antibiotics, added to systemic prophylaxis, to reduce
perineal wound infection in abdominoperineal excision of the
rectum. Acta Chir Scand 154: 589592.
Montejo JC, Zarazaga A, Lopez-Martinez J et al (2003)
Immunonutrition in the intensive care unit. A systematic review
and consensus statement. Clin Nutr 22: 221233.
Moore NM, Gardiner SN, Borak GD & Delegge MH (2004) Catheter
related infections in peripherally inserted central catheters versus
other centrally placed catheters in the home parenteral nutrition
patient. J Am Dietetic Assoc 104 (suppl 2): 25.
Moores LK & Tapson VF (2001) Vena caval filters in pulmonary
embolism. Semin Vasc Med 1(2): 221228.
Morris WT (1993) Ceftriaxone is more effective than
gentamicin/metronidazole prophylaxis in reducing wound and
urinary tract infections after bowel operations. Results of a
controlled, randomized, blind clinical trial. Dis Colon Rectum 36:
826833.
Morris DL, Hares MM, Voogt RJ et al (1983) Metronidazole need not
be combined with an aminoglycoside when used for prophylaxis in
elective colorectal surgery. J Hosp Infect 4: 6569.
Morris DL, Fabricius PJ, Ambrose NS et al (1984) A high incidence of
bleeding is observed in a trial to determine whether addition of
metronidazole is needed with latamoxef for prophylaxis in
colorectal surgery. J Hosp Infect 5: 398408.
Mosen D, Elliott CG, Egger MJ et al (2004) The effect of a computerized
reminder system on the prevention of postoperative venous
thromboembolism. Chest 125(5): 16351641.
Moskovitz DN, Kim YI (2004) Does perioperative immunonutrition
reduce postoperative complications in patients with gastrointestinal
cancer undergoing operations. Nutr Rev 62(11): 443447.
Moukhtar M & Romney S (1980) Continuous intraperitoneal
antibiotic lavage in the management of purulent sepsis of the
pelvis. Surg Gynec Obstet 150: 548550.
Moumjid N & Callu MF (2003) Informed consent and risk
communication in France. Br Med J 327: 734735.
Muir EG (1968) Safety in colonic resection. J R Soc Med 61: 401408.
Munro A, Steele RJC & Logie JRC (1987) Technique for intra-operative
colonic irrigation. Br J Surg 75: 10391040.
Murayama KM, Schneider PD & Thompson JS (1995) Laparoscopic
gastrostomy: a safe method for obtaining enteral access. J Surg Res
58(1): 15.
Mynster T, Nielsen HJ, Harling H & Bulow S; the Danish TME-group,
RANX05-group (2004) Blood loss and transfusion after total
mesorectal excision and conventional rectal cancer surgery.
Colorectal Dis 6(6): 452457.
Nagy GS (1981) Preparing the patient. In Hunt RH & Way JR (eds)
Colonoscopy, pp 3644. London: Chapman & Hall.
Nakafusa Y, Tanaka T, Tanaka M et al (2004) Comparison of
multivisceral resection and standard operation for locally advanced
colorectal cancer: analysis of prognostic factors for short-term and
long-term outcome. Dis Colon Rectum 47(12): 20552063.
References
135
136
Chapter 3
Perioperative Care
References
137
138
Chapter 3
Perioperative Care
References
139